Page last updated: 2024-11-08

dimethylphenylpiperazinium iodide and Hyperglycemia

dimethylphenylpiperazinium iodide has been researched along with Hyperglycemia in 1 studies

Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jall, S1
De Angelis, M1
Lundsgaard, AM1
Fritzen, AM1
Nicolaisen, TS1
Klein, AB1
Novikoff, A1
Sachs, S1
Richter, EA1
Kiens, B1
Schramm, KW1
Tschöp, MH1
Stemmer, K1
Clemmensen, C1
Müller, TD1
Kleinert, M1

Other Studies

1 other study available for dimethylphenylpiperazinium iodide and Hyperglycemia

ArticleYear
Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
    Diabetologia, 2020, Volume: 63, Issue:6

    Topics: Animals; Blood Glucose; Catecholamines; Dimethylphenylpiperazinium Iodide; Hyperglycemia; Insulin Re

2020